ARCHITECT 8D06-41Recalls & reported problems
Abbott GmbH · ARCHITECT Syphilis TP Reagent Kit · Class 1
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00380740117122), received between Sep 17, 2020 and Jul 11, 2024 — classified as 2 malfunctions.
The most frequently reported specific device problem is “False Negative Result” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Reports received per month
Most reported problems
Device problems
- False Negative Result2
Patient problems
- No Clinical Signs, Symptoms or Conditions1
- No Known Impact Or Consequence To Patient1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionJul 11, 2024False Negative Result; False Negative Result
THE CUSTOMER OBSERVED FALSE NONREACTIVE ARCHITECT SYPHILIS TP RESULTS FOR A NEWBORN WITH A POSITIVE SYPHILIS MOTHER. THE PATIENT WAS REDRAWN AND THE EXPECTED POSITIVE RESULT WAS OBTAINED. THE FOLLOWING DATA WAS PROVIDED (<1.00 S/CO IS NONREACTIVE, >/=1.00 S/CO IS REACTIVE): INITIAL RESULT = 0.87 S/CO SAMPLE WAS A SHORT SAMPLE. REDRAW SID (B)(6) RESULT = 21.62 S/CO NO IMPACT TO DONOR MANAGEMENT WAS REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 19723886 ↗MalfunctionSep 17, 2020False Negative Result; False Negative Result
THE CUSTOMER OBTAINED A FALSE NEGATIVE ARCHITECT SYPHILIS TP RESULT. THE SAMPLE GENERATED 0.13 AND RETEST ON SECOND ANALYZER 0.15 S/CO ON ARCHITECT. THE SAMPLE GENERATED POSITIVE RESULTS ON TPPA AND RPR METHODS. NO IMPACT TO PATIENT MANAGEMENT WAS REPORTED. NO IMPACT TO PATIENT MANAGEMENT WAS REPORTED.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 10545738 ↗
Other SINGLE (SPECIFIED) ANALYTE CONTROLS (ASSAYED AND UNASSAYED) devices
- CONTOUR® NEXT 7314Ascensia Diabetes Care US Inc. · Single (Specified) Analyte Controls (Assayed And Unassayed)227 reports
- FastPack® IP SHBG FastPack® IP SHBG 30 ImmunoassayQualigen Inc. · Single (Specified) Analyte Controls (Assayed And Unassayed)2 recalls0 reports
- CONTOUR® NEXT 7377Ascensia Diabetes Care US Inc. · Single (Specified) Analyte Controls (Assayed And Unassayed)95 reports
- ARCHITECT 7K62-25Abbott Ireland · SINGLE (SPECIFIED) ANALYTE CONTROLS (ASSAYED AND UNASSAYED)94 reports
- ARCHITECT 08K2812Abbott GmbH · Single (specified) analyte controls (assayed and unassayed)1 recall12 reports
- CONTOUR® NEXT 9697Ascensia Diabetes Care US Inc. · Single (Specified) Analyte Controls (Assayed And Unassayed)56 reports
- VITROS 6192257Ortho Clinical Diagnostics · Single (specified) analyte controls (assayed and unassayed)1 recall0 reports
- McKesson 5011Mckesson Medical-Surgical Inc. · Single (Specified) Analyte Controls (Assayed And Unassayed)1 recall0 reports
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.